Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)

Market Cap	24.69B -24.9%
Revenue (ttm)	8.55B -9.2%
Net Income	373.17M -67.4%
EPS	0.25 -68.5%
Shares Out	1.49B
PE Ratio	66.61
Forward PE	19.73
Dividend	0.10 (0.60%)
Ex-Dividend Date	Jun 18, 2026

Volume	46,135,016
Open	16.51
Previous Close	16.57
Day's Range	16.10 - 16.76
52-Week Range	13.73 - 27.97
Beta	0.18
Analysts	Hold
Price Target	18.20 (+9.44%)
Earnings Date	Aug 27, 2026

About SHA:600521

Zhejiang Huahai Pharmaceutical Co., Ltd. engaged in the research, development, production, and sales of generic drugs, biologics, drugs, and specialty active pharmaceutical ingredients in multiple dosage forms in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as polyethylene bottles and polypropylene caps for pharmaceuticals. In addition, the company offers contract manufacturing and other services,...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 8,797
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600521

Financial Performance

In 2025, SHA:600521's revenue was 8.59 billion, a decrease of -10.06% compared to the previous year's 9.55 billion. Earnings were 266.40 million, a decrease of -76.19%.

Analyst Summary

According to 3 analysts, the average rating for 600521 stock is "Hold." The 12-month stock price target is ¥18.20, which is an increase of 9.44% from the latest price.

Price Target

¥18.20

(9.44% upside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 21, 2026

Data Sources Report a data error